Update on clinical heart failure trials

Area of Science:

• Cardiology
• Clinical Trials
• Pharmacology

Background:

• Heart failure (HF) presents a significant global health challenge with increasing prevalence.
• Despite diagnostic and management advancements, HF continues to cause substantial morbidity and mortality.

Purpose of the Study:

• To provide a comprehensive review of recent pivotal clinical trials in heart failure.
• To highlight advancements in pharmacological therapies, patient phenotyping, and comorbidity management across different HF types (HFrEF, HFmrEF, HFpEF).

Main Methods:

• Review of key clinical trials (e.g., DIGIT-HF, VICTORIA, VICTOR, STRONG-HF, SUMMIT, STEP-HFpEF) published or presented recently.
• Analysis of trial implications for current practice and future guidelines.

Main Results:

• Novel pharmacological therapies are emerging for various heart failure phenotypes.
• Patient phenotyping and comorbidity management strategies are evolving.
• Several trials demonstrate practice-changing implications for HF treatment.

Conclusions:

• The therapeutic landscape for heart failure is rapidly evolving with new trial data.
• These advancements are crucial for improving patient outcomes and shaping future treatment guidelines for all HF types.